1. Research Framework

1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation

2. Research Methodology

2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation

3. Executive Summary: Japan Epigenetics Market

Executive Summary: Japan Epigenetics Market

4. Japan Epigenetics Market Overview

4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User
4.2. Industry Outlook
4.2.1. Advances in Epigenetic Technology
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Market Growth and Outlook
4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2023 - 2032
4.7. Competition Dashboard
4.7.1. Market Concentration Rate
4.7.2. Company Market Share Analysis (Value %), 2020
4.7.3. Competitor Mapping

5. Japan Epigenetics Market, By Product Type

5.1. Key Insights
5.2. Market Size and Forecast, 2023 - 2032 (US$ Mn)
5.2.1. Reagents
5.2.2. Kits
5.2.2.1. Bisulfite Conversion Kits
5.2.2.2. ChIP Kits
5.2.2.3. RNA kits
5.2.2.4. Others
5.2.3. Instruments
5.2.4. Software Tools
5.2.4.1. EpiGRAPH
5.2.4.2. BiQ Analyzer
5.2.4.3. RnBeads
5.2.4.4. Others
5.2.5. Enzymes
5.2.6. Proteins & Peptides
5.2.7. Antibodies
5.2.8. Services

6. Japan Epigenetics Market, By Technology

6.1. Key Insights
6.2. Market Size and Forecast, 2023 - 2032 (US$ Mn)
6.2.1. DNA Methylation
6.2.2. Histone Methylation
6.2.3. Histone Acetylation
6.2.4. Bromodomains
6.2.5. Non-Coding RNA
6.2.6. Others

7. Japan Epigenetics Market, By Application

7.1. Key Insights

7.2. Market Size and Forecast, 2023 - 2032 (US$ Mn)
7.2.1. Oncology
7.2.2. Non-Oncology
7.2.2.1. Cardiovascular Diseases
7.2.2.2. Neurodegenerative

7.2.2.3. Autoimmune

8. Japan Epigenetics Market, By End Users

8.1. Key Insights
8.2. Market Size and Forecast, 2023 - 2032 (US$ Mn)
8.2.1. Academic and Research Institutes
8.2.2. Pharmaceutical & Biotechnology Companies
8.2.3. Contract Research Organizations (CROs)
8.2.4. Research and consulting firms

9. Company Profile (Company Overview, Financial Matrix, Sales Composition Ration, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

9.1. Roche Diagnostics KK
9.2. Novartis Pharma K. K
9.3. Eisai Co. Ltd.
9.4. Illumina K. K.
9.5. Promega KK
9.6. Tomy Digital Biology Co., Ltd.
9.7. Takeda Pharmaceutical Company Limited
9.8. Ac-Planta Inc.
9.9. Rhelixa, Inc.
9.10. Funakoshi Co. Ltd.
9.11 Others